Nav: Home > Health > Disease News

The ministry of health issued by the a/H1N1 flu prevention medication guide close contacts

general office of the ministry of health, about print and distribute the influenza a (H1N1) in close contact with relevant staff preventive medication guide (trial edition) 2009 "to inform the provinces, autonomous regions and municipalities directly under the central government health bureaus, the xinjiang production and construction corps health bureau:

to get the a/H1N1 flu epidemic prevention and control work, as far as possible to prevent related people in close contact with infected, delay and reduce secondary cases, refer to the United States centers for disease control and prevention of influenza a (H1N1) patients and close contacts antiviral treatment interim guidance (on May 6, 2009 edition) and the world health organization (who) during the influenza pandemic vaccines and anti-viral drugs application guide (2004 edition), the prevention and control of influenza a (H1N1) preliminary experience in our country, the ministry of influenza a (H1N1) clinical expert group has established the influenza a (H1N1) in close contact with relevant staff preventive medication guide (trial edition) 2009 "(hereinafter referred to as" guidelines "). Hereby printed and distributed to you for reference in the process of the a/H1N1 flu prevention and control work. With the deepening of the understanding of influenza a (H1N1) and prevention situation change, I will organize experts to guide timely revision.

in the current epidemic situation, in close contact with drug related personnel to take preventive measures, must be combined with the outbreak and drug supply, by the provincial experts in research, clinical used by clinicians prescription, do strict control, prudent use of drugs, to ensure the medical quality and medical safety.

in the process of preventive medicine, to strengthen the monitoring of adverse drug reactions, for adverse reactions, to take timely treatment measures, and according to the relevant provisions of the report.

the ministry of health of the general office of June 1, 2009 influenza a (H1N1) in close contact with relevant staff preventive medication guide (trial edition) 2009

to effectively deal with the a/H1N1 flu outbreak, as far as possible to prevent related people in close contact with infected, delay and reduce secondary cases, refer to the United States centers for disease control and prevention of influenza a (H1N1) patients and close contacts antiviral treatment interim guidance (on May 6, 2009 edition) and the world health organization (who) during the influenza pandemic vaccines and anti-viral drugs application guide (2004 edition), the prevention and control of influenza a (H1N1) preliminary experience in our country, the guidelines are formulated.

close contacts referred to in this guidance refers to under the condition of not take effective protective phase contact transmission of influenza a (H1N1) cases, including: diagnosis, treatment or care, visit the a/H1N1 flu cases of personnel; Had a close contact with cases of common life or personnel; Cases or direct contact with respiratory secretions and body fluids; Or may be exposed to cases of pollution of the environment or objects, etc.

a, the prophylactic use of antiviral drugs

(a) applicable people.

1. Influenza a (H1N1) close contacts in the high-risk groups.

the high risk population is infected with influenza a (H1N1) virus after prone to severe complications and even death of people, including:

(1) children under the age of five years (2 years old the following severe complications occurred more often).

(2) more than 65 years old and the elderly;

(3) pregnant women;

(4) with the following conditions: the disease of chronic respiratory disease, cardiovascular (except for high blood pressure), blood, nerve, neuromuscular system or kidney, liver, metabolic and endocrine diseases, immunity inhibitor (including the application of immunosuppressant or HIV infection cause of low immune function etc.), long-term aspirin use is under the age of 19

(5) the collective life in the nursing home or other chronic disease rehabilitation agency personnel.

2. In the prevention and control work, nearly 7 days without effective protection, close contact with infected period of influenza a (H1N1) suspected or confirmed cases of medical staff, and public health personnel, laboratories and other relevant staff.

3. Other influenza a (H1N1) close contacts. This kind of personnel by the comprehensive analysis of medical practitioners after the exposure of the frequency, intensity and time, the existing high risk of infection can give preventive medicine.

(2) preventive application.

1. Oseltamivir (oseltamivir)

points to conform to preventive medicine, suggest that early (for) within 48 hours after exposure to taking oseltamivir, adult oral 75 mg, 1 times a day, stay to the last 7 to 10 days after exposure; Not within 48 hours after exposure to people, still suggest preventive medicine, 1 times a day, stay to the last 7-10 days after exposure.